DHR Stock Analysis: Buy, Sell, or Hold?
DHR - Danaher Corporation
$177.75
-0.44 (-0.25%)
▼
5d:
-1.85%
30d:
+2.55%
90d:
-6.45%
BUY
MODERATE Confidence
Analysis Updated: Jun 22, 2026 12:00 AM ET
Earnings: Jul 28, 2026
Smart Money Accumulation
None View Scanner →
Strength: 10.0/10
Get Alerted When DHR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: DHR shows positive signals but monitor for confirmation. Market pricing in 5.4% decline. Moderate conviction.
💡 BUY OPPORTUNITY: DHR shows positive signals but monitor for confirmation. Market pricing in 5.4% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$285.42
Based on 6.3% avg growth
INTRINSIC VALUE TODAY
$177.22
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 22.8x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: DHR is currently trading at $177.75, which is considered fair relative to its 30-day fair value range of $170.02 to $183.83. From a valuation perspective, the stock is trading at a discount (Forward PE: 19.3) compared to its historical average (22.8). Remarkably, the market is currently pricing in an annual earnings decline of 5.4% over the next few years. This pessimistic expectation contrasts with the company's recent 9.8% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, DHR is in a strong downtrend. The price is currently testing key support at $174.22. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $242.35 (+36.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, DHR is in a strong downtrend. The price is currently testing key support at $174.22. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $242.35 (+36.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$170.02 -
$183.83
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
72.4%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 36.0% below Wall St target ($242.35)
Trading Range Analysis
30-Day Trading Range
$170.02 -
$183.83
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$174.22
Resistance Level
$189.21
Current Trend
Strong Downtrend
Technical data as of
Jun 22, 2026
Fundamental Context
Forward P/E (Next Year Est.)
19.26
Wall Street Target
$242.35
(+36.0%)
Revenue Growth (YoY)
3.7%
Earnings Growth (YoY)
9.8%
Profit Margin
14.9%
Valuation Discount vs History
-5.4% cheaper
PE vs Historical
19.3 vs 22.8
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-5.4%
(market-implied from PE analysis)
1-Year Target
$168.57
(-5%)
2-Year Target
$159.47
(-11%)
3-Year Target
$150.85
(-15%)
3-Yr Target (if PE normalizes)
(PE: 19→23)
$178.55
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 8.5%)
$257.54
(+45%)
Base:
(SPY PE: 19.3, Growth: 8.5%)
$227.78
(+28%)
Bear:
(PE: 16.4, Growth: 8.5%)
$193.61
(+9%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (34x PE), but valuation improves significantly next year (19x PE) as earnings recover.
Trailing PE: 34.34 | Current EPS (TTM): $5.16
Bull Case
$349.37
(+96%)
Analyst growth 79.3%, PE expands to 37.8
Base Case
$317.61
(+78%)
Market implied 79.3%, PE stable at 34.3
Bear Case
$120.48
(-32%)
Severe decline -20.0%, PE contracts to 29.2
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 19.3 to 22.8
Stabilization Target:
$210.90
(+18.4%)
PE Expansion Potential:
+18.4%
Share & Embed Analysis
Last updated: June 23, 2026 11:11 AM ET
Data refreshes hourly during market hours. Next update: 12:11 PM
Data refreshes hourly during market hours. Next update: 12:11 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is DHR showing a specific setup today?
Insider Activity (6 Months)
1
Buys
5
Sells
Net
INSIDERS SELLING
Recent Transactions
Ro Khanna
SELL
2026-03-23
Ro Khanna
BUY
2026-03-10
Ro Khanna
SELL
2026-02-24
Featured in Portfolios
DHR is a key holding in these high-performance investment strategies.
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$599 | 55 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 65 BUY |
|
GH
Guardant Health Inc |
STRONG BUY
23 analysts |
$142 | 56 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$260 | 62 BUY |
|
LH
Laboratory Corporation o… |
STRONG BUY
20 analysts |
$310 | 60 HOLD |
Advanced DHR Option Strategies
Professional options setups generated by AI based on today's DHR price and gamma walls.
